SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).
It becomes the 8th COVID-19 vaccine authorised by the UK’s independent medicines regulator.
The authorisation follows advice received from the independent Commission on Human Medicines (CHM).
The SKYCovion vaccine combines a part of the SARS-CoV-2 virus spike protein with an ‘adjuvant’ – an additional ingredient designed to trigger a stronger immune response. It is given as two injections, four weeks part…